Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Related Articles by Review for PubMed (Select 21659868)

1.

The hypoxia-inflammation link and potential drug targets.

Koeppen M, Eckle T, Eltzschig HK.

Curr Opin Anaesthesiol. 2011 Aug;24(4):363-9. doi: 10.1097/ACO.0b013e32834873fd. Review.

2.

Hypoxia signaling during intestinal ischemia and inflammation.

Grenz A, Clambey E, Eltzschig HK.

Curr Opin Crit Care. 2012 Apr;18(2):178-85. doi: 10.1097/MCC.0b013e3283514bd0. Review.

3.

The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease.

Tanaka T, Nangaku M.

Curr Opin Nephrol Hypertens. 2010 Jan;19(1):43-50. doi: 10.1097/MNH.0b013e3283328eed. Review.

PMID:
19779337
4.

The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.

Brahimi-Horn C, Pouysségur J.

Bull Cancer. 2006 Aug;93(8):E73-80. Review.

PMID:
16935775
5.

Hypoxia-inducible factor as a therapeutic target for cardioprotection.

Ong SG, Hausenloy DJ.

Pharmacol Ther. 2012 Oct;136(1):69-81. doi: 10.1016/j.pharmthera.2012.07.005. Epub 2012 Jul 16. Review.

PMID:
22800800
6.
7.

Erythropoietin gene regulation depends on heme-dependent oxygen sensing and assembly of interacting transcription factors.

Huang LE, Ho V, Arany Z, Krainc D, Galson D, Tendler D, Livingston DM, Bunn HF.

Kidney Int. 1997 Feb;51(2):548-52. Review.

PMID:
9027736
8.

Hypoxia-inducible factor 1 in lower limb ischemia.

Ho TK, Abraham DJ, Black CM, Baker DM.

Vascular. 2006 Nov-Dec;14(6):321-7. Review.

PMID:
17150152
9.

Targeting the hypoxia-inducible factor (HIF) pathway in cancer.

Poon E, Harris AL, Ashcroft M.

Expert Rev Mol Med. 2009 Aug 27;11:e26. doi: 10.1017/S1462399409001173. Review.

PMID:
19709449
10.

Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy.

Ratan RR, Siddiq A, Aminova L, Lange PS, Langley B, Ayoub I, Gensert J, Chavez J.

Stroke. 2004 Nov;35(11 Suppl 1):2687-9. Epub 2004 Oct 7. Review.

11.

Expression of hypoxia-inducible factor 1: mechanisms and consequences.

Semenza GL.

Biochem Pharmacol. 2000 Jan 1;59(1):47-53. Review.

PMID:
10605934
12.

Integration of oxygen signaling at the consensus HRE.

Wenger RH, Stiehl DP, Camenisch G.

Sci STKE. 2005 Oct 18;2005(306):re12. Review.

PMID:
16234508
13.

Hypoxia and the HIF system in kidney disease.

Nangaku M, Eckardt KU.

J Mol Med (Berl). 2007 Dec;85(12):1325-30. Epub 2007 Nov 20. Review.

PMID:
18026918
15.

The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling.

Berra E, Ginouvès A, Pouysségur J.

EMBO Rep. 2006 Jan;7(1):41-5. Review.

16.
17.

The HIF pathway: implications for patterns of gene expression in cancer.

Wykoff CC, Pugh CW, Harris AL, Maxwell PH, Ratcliffe PJ.

Novartis Found Symp. 2001;240:212-25; discussion 225-31. Review.

PMID:
11727931
18.

Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.

Rohwer N, Cramer T.

Drug Resist Updat. 2011 Jun;14(3):191-201. doi: 10.1016/j.drup.2011.03.001. Epub 2011 Apr 3. Review.

PMID:
21466972
19.

Hypoxia-inducible factor-1 in arterial disease: a putative therapeutic target.

Kasivisvanathan V, Shalhoub J, Lim CS, Shepherd AC, Thapar A, Davies AH.

Curr Vasc Pharmacol. 2011 May;9(3):333-49. Review.

PMID:
20807188
20.

Regulation of gene expression by the hypoxia-inducible factors.

Fedele AO, Whitelaw ML, Peet DJ.

Mol Interv. 2002 Jul;2(4):229-43. Review.

PMID:
14993394
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk